1 Market Overview 1.1 Product Overview and Scope of Cystinosis Treatment 1.2 Classification of Cystinosis Treatment by Type 1.2.1 Overview: Global Cystinosis Treatment Market Size by Type: 2017 Versus 2021 Versus 2028 1.2.2 Global Cystinosis Treatment Revenue Market Share by Type in 2021 1.2.3 Cysteine Depleting Therapy 1.2.4 Symptomatic Therapy 1.2.5 Renal Transplantation 1.3 Global Cystinosis Treatment Market by Application 1.3.1 Overview: Global Cystinosis Treatment Market Size by Application: 2017 Versus 2021 Versus 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Others 1.4 Global Cystinosis Treatment Market Size & Forecast 1.5 Global Cystinosis Treatment Market Size and Forecast by Region 1.5.1 Global Cystinosis Treatment Market Size by Region: 2017 VS 2021 VS 2028 1.5.2 Global Cystinosis Treatment Market Size by Region, (2017-2022) 1.5.3 North America Cystinosis Treatment Market Size and Prospect (2017-2028) 1.5.4 Europe Cystinosis Treatment Market Size and Prospect (2017-2028) 1.5.5 Asia-Pacific Cystinosis Treatment Market Size and Prospect (2017-2028) 1.5.6 South America Cystinosis Treatment Market Size and Prospect (2017-2028) 1.5.7 Middle East and Africa Cystinosis Treatment Market Size and Prospect (2017-2028) 1.6 Market Drivers, Restraints and Trends 1.6.1 Cystinosis Treatment Market Drivers 1.6.2 Cystinosis Treatment Market Restraints 1.6.3 Cystinosis Treatment Trends Analysis 2 Company Profiles 2.1 AVROBIO, Inc. 2.1.1 AVROBIO, Inc. Details 2.1.2 AVROBIO, Inc. Major Business 2.1.3 AVROBIO, Inc. Cystinosis Treatment Product and Solutions 2.1.4 AVROBIO, Inc. Cystinosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.1.5 AVROBIO, Inc. Recent Developments and Future Plans 2.2 Gilead Sciences, Inc. 2.2.1 Gilead Sciences, Inc. Details 2.2.2 Gilead Sciences, Inc. Major Business 2.2.3 Gilead Sciences, Inc. Cystinosis Treatment Product and Solutions 2.2.4 Gilead Sciences, Inc. Cystinosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.2.5 Gilead Sciences, Inc. Recent Developments and Future Plans 2.3 Mylan 2.3.1 Mylan Details 2.3.2 Mylan Major Business 2.3.3 Mylan Cystinosis Treatment Product and Solutions 2.3.4 Mylan Cystinosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.3.5 Mylan Recent Developments and Future Plans 2.4 Novartis 2.4.1 Novartis Details 2.4.2 Novartis Major Business 2.4.3 Novartis Cystinosis Treatment Product and Solutions 2.4.4 Novartis Cystinosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.4.5 Novartis Recent Developments and Future Plans 2.5 Horizon Therapeutics 2.5.1 Horizon Therapeutics Details 2.5.2 Horizon Therapeutics Major Business 2.5.3 Horizon Therapeutics Cystinosis Treatment Product and Solutions 2.5.4 Horizon Therapeutics Cystinosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.5.5 Horizon Therapeutics Recent Developments and Future Plans 2.6 Chiesi Farmaceutici S.p.A. 2.6.1 Chiesi Farmaceutici S.p.A. Details 2.6.2 Chiesi Farmaceutici S.p.A. Major Business 2.6.3 Chiesi Farmaceutici S.p.A. Cystinosis Treatment Product and Solutions 2.6.4 Chiesi Farmaceutici S.p.A. Cystinosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.6.5 Chiesi Farmaceutici S.p.A. Recent Developments and Future Plans 2.7 Leadiant Biosciences, Inc. 2.7.1 Leadiant Biosciences, Inc. Details 2.7.2 Leadiant Biosciences, Inc. Major Business 2.7.3 Leadiant Biosciences, Inc. Cystinosis Treatment Product and Solutions 2.7.4 Leadiant Biosciences, Inc. Cystinosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.7.5 Leadiant Biosciences, Inc. Recent Developments and Future Plans 3 Market Competition, by Players 3.1 Global Cystinosis Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022) 3.2 Market Concentration Rate 3.2.1 Top 3 Cystinosis Treatment Players Market Share in 2021 3.2.2 Top 10 Cystinosis Treatment Players Market Share in 2021 3.2.3 Market Competition Trend 3.3 Cystinosis Treatment Players Head Office, Products and Services Provided 3.4 Cystinosis Treatment Mergers & Acquisitions 3.5 Cystinosis Treatment New Entrants and Expansion Plans 4 Market Size Segment by Type 4.1 Global Cystinosis Treatment Revenue and Market Share by Type (2017-2022) 4.2 Global Cystinosis Treatment Market Forecast by Type (2023-2028) 5 Market Size Segment by Application 5.1 Global Cystinosis Treatment Revenue Market Share by Application (2017-2022) 5.2 Global Cystinosis Treatment Market Forecast by Application (2023-2028) 6 North America by Country, by Type, and by Application 6.1 North America Cystinosis Treatment Revenue by Type (2017-2028) 6.2 North America Cystinosis Treatment Revenue by Application (2017-2028) 6.3 North America Cystinosis Treatment Market Size by Country 6.3.1 North America Cystinosis Treatment Revenue by Country (2017-2028) 6.3.2 United States Cystinosis Treatment Market Size and Forecast (2017-2028) 6.3.3 Canada Cystinosis Treatment Market Size and Forecast (2017-2028) 6.3.4 Mexico Cystinosis Treatment Market Size and Forecast (2017-2028) 7 Europe by Country, by Type, and by Application 7.1 Europe Cystinosis Treatment Revenue by Type (2017-2028) 7.2 Europe Cystinosis Treatment Revenue by Application (2017-2028) 7.3 Europe Cystinosis Treatment Market Size by Country 7.3.1 Europe Cystinosis Treatment Revenue by Country (2017-2028) 7.3.2 Germany Cystinosis Treatment Market Size and Forecast (2017-2028) 7.3.3 France Cystinosis Treatment Market Size and Forecast (2017-2028) 7.3.4 United Kingdom Cystinosis Treatment Market Size and Forecast (2017-2028) 7.3.5 Russia Cystinosis Treatment Market Size and Forecast (2017-2028) 7.3.6 Italy Cystinosis Treatment Market Size and Forecast (2017-2028) 8 Asia-Pacific by Region, by Type, and by Application 8.1 Asia-Pacific Cystinosis Treatment Revenue by Type (2017-2028) 8.2 Asia-Pacific Cystinosis Treatment Revenue by Application (2017-2028) 8.3 Asia-Pacific Cystinosis Treatment Market Size by Region 8.3.1 Asia-Pacific Cystinosis Treatment Revenue by Region (2017-2028) 8.3.2 China Cystinosis Treatment Market Size and Forecast (2017-2028) 8.3.3 Japan Cystinosis Treatment Market Size and Forecast (2017-2028) 8.3.4 South Korea Cystinosis Treatment Market Size and Forecast (2017-2028) 8.3.5 India Cystinosis Treatment Market Size and Forecast (2017-2028) 8.3.6 Southeast Asia Cystinosis Treatment Market Size and Forecast (2017-2028) 8.3.7 Australia Cystinosis Treatment Market Size and Forecast (2017-2028) 9 South America by Country, by Type, and by Application 9.1 South America Cystinosis Treatment Revenue by Type (2017-2028) 9.2 South America Cystinosis Treatment Revenue by Application (2017-2028) 9.3 South America Cystinosis Treatment Market Size by Country 9.3.1 South America Cystinosis Treatment Revenue by Country (2017-2028) 9.3.2 Brazil Cystinosis Treatment Market Size and Forecast (2017-2028) 9.3.3 Argentina Cystinosis Treatment Market Size and Forecast (2017-2028) 10 Middle East & Africa by Country, by Type, and by Application 10.1 Middle East & Africa Cystinosis Treatment Revenue by Type (2017-2028) 10.2 Middle East & Africa Cystinosis Treatment Revenue by Application (2017-2028) 10.3 Middle East & Africa Cystinosis Treatment Market Size by Country 10.3.1 Middle East & Africa Cystinosis Treatment Revenue by Country (2017-2028) 10.3.2 Turkey Cystinosis Treatment Market Size and Forecast (2017-2028) 10.3.3 Saudi Arabia Cystinosis Treatment Market Size and Forecast (2017-2028) 10.3.4 UAE Cystinosis Treatment Market Size and Forecast (2017-2028) 11 Research Findings and Conclusion 12 Appendix 12.1 Methodology 12.2 Research Process and Data Source 12.3 Disclaimer

List of Tables Table 1. Global Cystinosis Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028 Table 2. Global Cystinosis Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028 Table 3. Global Market Cystinosis Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028) Table 4. Global Cystinosis Treatment Revenue (USD Million) by Region (2017-2022) Table 5. Global Cystinosis Treatment Revenue Market Share by Region (2023-2028) Table 6. AVROBIO, Inc. Corporate Information, Head Office, and Major Competitors Table 7. AVROBIO, Inc. Major Business Table 8. AVROBIO, Inc. Cystinosis Treatment Product and Solutions Table 9. AVROBIO, Inc. Cystinosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 10. Gilead Sciences, Inc. Corporate Information, Head Office, and Major Competitors Table 11. Gilead Sciences, Inc. Major Business Table 12. Gilead Sciences, Inc. Cystinosis Treatment Product and Solutions Table 13. Gilead Sciences, Inc. Cystinosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 14. Mylan Corporate Information, Head Office, and Major Competitors Table 15. Mylan Major Business Table 16. Mylan Cystinosis Treatment Product and Solutions Table 17. Mylan Cystinosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 18. Novartis Corporate Information, Head Office, and Major Competitors Table 19. Novartis Major Business Table 20. Novartis Cystinosis Treatment Product and Solutions Table 21. Novartis Cystinosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 22. Horizon Therapeutics Corporate Information, Head Office, and Major Competitors Table 23. Horizon Therapeutics Major Business Table 24. Horizon Therapeutics Cystinosis Treatment Product and Solutions Table 25. Horizon Therapeutics Cystinosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 26. Chiesi Farmaceutici S.p.A. Corporate Information, Head Office, and Major Competitors Table 27. Chiesi Farmaceutici S.p.A. Major Business Table 28. Chiesi Farmaceutici S.p.A. Cystinosis Treatment Product and Solutions Table 29. Chiesi Farmaceutici S.p.A. Cystinosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 30. Leadiant Biosciences, Inc. Corporate Information, Head Office, and Major Competitors Table 31. Leadiant Biosciences, Inc. Major Business Table 32. Leadiant Biosciences, Inc. Cystinosis Treatment Product and Solutions Table 33. Leadiant Biosciences, Inc. Cystinosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 34. Global Cystinosis Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022) Table 35. Global Cystinosis Treatment Revenue Share by Players (2019, 2020, 2021, and 2022) Table 36. Breakdown of Cystinosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3) Table 37. Cystinosis Treatment Players Head Office, Products and Services Provided Table 38. Cystinosis Treatment Mergers & Acquisitions in the Past Five Years Table 39. Cystinosis Treatment New Entrants and Expansion Plans Table 40. Global Cystinosis Treatment Revenue (USD Million) by Type (2017-2022) Table 41. Global Cystinosis Treatment Revenue Share by Type (2017-2022) Table 42. Global Cystinosis Treatment Revenue Forecast by Type (2023-2028) Table 43. Global Cystinosis Treatment Revenue by Application (2017-2022) Table 44. Global Cystinosis Treatment Revenue Forecast by Application (2023-2028) Table 45. North America Cystinosis Treatment Revenue by Type (2017-2022) & (USD Million) Table 46. North America Cystinosis Treatment Revenue by Type (2023-2028) & (USD Million) Table 47. North America Cystinosis Treatment Revenue by Application (2017-2022) & (USD Million) Table 48. North America Cystinosis Treatment Revenue by Application (2023-2028) & (USD Million) Table 49. North America Cystinosis Treatment Revenue by Country (2017-2022) & (USD Million) Table 50. North America Cystinosis Treatment Revenue by Country (2023-2028) & (USD Million) Table 51. Europe Cystinosis Treatment Revenue by Type (2017-2022) & (USD Million) Table 52. Europe Cystinosis Treatment Revenue by Type (2023-2028) & (USD Million) Table 53. Europe Cystinosis Treatment Revenue by Application (2017-2022) & (USD Million) Table 54. Europe Cystinosis Treatment Revenue by Application (2023-2028) & (USD Million) Table 55. Europe Cystinosis Treatment Revenue by Country (2017-2022) & (USD Million) Table 56. Europe Cystinosis Treatment Revenue by Country (2023-2028) & (USD Million) Table 57. Asia-Pacific Cystinosis Treatment Revenue by Type (2017-2022) & (USD Million) Table 58. Asia-Pacific Cystinosis Treatment Revenue by Type (2023-2028) & (USD Million) Table 59. Asia-Pacific Cystinosis Treatment Revenue by Application (2017-2022) & (USD Million) Table 60. Asia-Pacific Cystinosis Treatment Revenue by Application (2023-2028) & (USD Million) Table 61. Asia-Pacific Cystinosis Treatment Revenue by Region (2017-2022) & (USD Million) Table 62. Asia-Pacific Cystinosis Treatment Revenue by Region (2023-2028) & (USD Million) Table 63. South America Cystinosis Treatment Revenue by Type (2017-2022) & (USD Million) Table 64. South America Cystinosis Treatment Revenue by Type (2023-2028) & (USD Million) Table 65. South America Cystinosis Treatment Revenue by Application (2017-2022) & (USD Million) Table 66. South America Cystinosis Treatment Revenue by Application (2023-2028) & (USD Million) Table 67. South America Cystinosis Treatment Revenue by Country (2017-2022) & (USD Million) Table 68. South America Cystinosis Treatment Revenue by Country (2023-2028) & (USD Million) Table 69. Middle East & Africa Cystinosis Treatment Revenue by Type (2017-2022) & (USD Million) Table 70. Middle East & Africa Cystinosis Treatment Revenue by Type (2023-2028) & (USD Million) Table 71. Middle East & Africa Cystinosis Treatment Revenue by Application (2017-2022) & (USD Million) Table 72. Middle East & Africa Cystinosis Treatment Revenue by Application (2023-2028) & (USD Million) Table 73. Middle East & Africa Cystinosis Treatment Revenue by Country (2017-2022) & (USD Million) Table 74. Middle East & Africa Cystinosis Treatment Revenue by Country (2023-2028) & (USD Million) List of Figures Figure 1. Cystinosis Treatment Picture Figure 2. Global Cystinosis Treatment Revenue Market Share by Type in 2021 Figure 3. Cysteine Depleting Therapy Figure 4. Symptomatic Therapy Figure 5. Renal Transplantation Figure 6. Cystinosis Treatment Revenue Market Share by Application in 2021 Figure 7. Hospitals Picture Figure 8. Clinics Picture Figure 9. Ambulatory Surgical Centers Picture Figure 10. Others Picture Figure 11. Global Cystinosis Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028 Figure 12. Global Cystinosis Treatment Revenue and Forecast (2017-2028) & (USD Million) Figure 13. Global Cystinosis Treatment Revenue Market Share by Region (2017-2028) Figure 14. Global Cystinosis Treatment Revenue Market Share by Region in 2021 Figure 15. North America Cystinosis Treatment Revenue (USD Million) and Growth Rate (2017-2028) Figure 16. Europe Cystinosis Treatment Revenue (USD Million) and Growth Rate (2017-2028) Figure 17. Asia-Pacific Cystinosis Treatment Revenue (USD Million) and Growth Rate (2017-2028) Figure 18. South America Cystinosis Treatment Revenue (USD Million) and Growth Rate (2017-2028) Figure 19. Middle East and Africa Cystinosis Treatment Revenue (USD Million) and Growth Rate (2017-2028) Figure 20. Cystinosis Treatment Market Drivers Figure 21. Cystinosis Treatment Market Restraints Figure 22. Cystinosis Treatment Market Trends Figure 23. AVROBIO, Inc. Recent Developments and Future Plans Figure 24. Gilead Sciences, Inc. Recent Developments and Future Plans Figure 25. Mylan Recent Developments and Future Plans Figure 26. Novartis Recent Developments and Future Plans Figure 27. Horizon Therapeutics Recent Developments and Future Plans Figure 28. Chiesi Farmaceutici S.p.A. Recent Developments and Future Plans Figure 29. Leadiant Biosciences, Inc. Recent Developments and Future Plans Figure 30. Global Cystinosis Treatment Revenue Share by Players in 2021 Figure 31. Cystinosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021 Figure 32. Global Top 3 Players Cystinosis Treatment Revenue Market Share in 2021 Figure 33. Global Top 10 Players Cystinosis Treatment Revenue Market Share in 2021 Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022) Figure 35. Global Cystinosis Treatment Revenue Share by Type in 2021 Figure 36. Global Cystinosis Treatment Market Share Forecast by Type (2023-2028) Figure 37. Global Cystinosis Treatment Revenue Share by Application in 2021 Figure 38. Global Cystinosis Treatment Market Share Forecast by Application (2023-2028) Figure 39. North America Cystinosis Treatment Sales Market Share by Type (2017-2028) Figure 40. North America Cystinosis Treatment Sales Market Share by Application (2017-2028) Figure 41. North America Cystinosis Treatment Revenue Market Share by Country (2017-2028) Figure 42. United States Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 43. Canada Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 44. Mexico Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 45. Europe Cystinosis Treatment Sales Market Share by Type (2017-2028) Figure 46. Europe Cystinosis Treatment Sales Market Share by Application (2017-2028) Figure 47. Europe Cystinosis Treatment Revenue Market Share by Country (2017-2028) Figure 48. Germany Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 49. France Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 50. United Kingdom Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 51. Russia Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. Italy Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 53. Asia-Pacific Cystinosis Treatment Sales Market Share by Type (2017-2028) Figure 54. Asia-Pacific Cystinosis Treatment Sales Market Share by Application (2017-2028) Figure 55. Asia-Pacific Cystinosis Treatment Revenue Market Share by Region (2017-2028) Figure 56. China Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 57. Japan Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. South Korea Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. India Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Southeast Asia Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Australia Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 62. South America Cystinosis Treatment Sales Market Share by Type (2017-2028) Figure 63. South America Cystinosis Treatment Sales Market Share by Application (2017-2028) Figure 64. South America Cystinosis Treatment Revenue Market Share by Country (2017-2028) Figure 65. Brazil Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 66. Argentina Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. Middle East and Africa Cystinosis Treatment Sales Market Share by Type (2017-2028) Figure 68. Middle East and Africa Cystinosis Treatment Sales Market Share by Application (2017-2028) Figure 69. Middle East and Africa Cystinosis Treatment Revenue Market Share by Country (2017-2028) Figure 70. Turkey Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 71. Saudi Arabia Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 72. UAE Cystinosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million) Figure 73. Methodology Figure 74. Research Process and Data Source

AVROBIO, Inc. Gilead Sciences, Inc. Mylan Novartis Horizon Therapeutics Chiesi Farmaceutici S.p.A. Leadiant Biosciences, Inc.